ZYNLONTA ® is a prescription medicine used to treat adults with certain types of large B-cell lymphoma that has come back (relapsed) or that did not respond to previous treatment …

Loncastuximab tesirine, sold under the brand name Zynlonta, is a monoclonal antibody conjugate medication used to treat large B-cell lymphoma and high-grade B-cell lymphoma. [1] [2] It is an …

ZYNLONTA is indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse...

ZYNLONTA ® is a prescription medicine used to treat adults with certain types of large B-cell lymphoma that has come back (relapsed) or that did not respond to previous treatment …

2024年7月12日 · ZYNLONTA is indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse …

2025年2月16日 · Zynlonta is an FDA-approved treatment for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in adults after two or more lines of systemic therapy. Relapsed …

2022年4月1日 · ZYNLONTA ® is indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse …

2020年6月16日 · Learn about the mechanism of action of ZYNLONTA® (loncastuximab tesirine-lpyl), the only CD19-targeted antibody-drug conjugate engineered to deliver a potent payload. …

2023年7月20日 · ZYNLONTA is used to treat adults with certain types of large B-cell lymphoma whose disease has come back or has not improved after at least two previous treatments.

2024年7月13日 · What is Zynlonta used for? Zynlonta (loncastuximab tesirine-lpyl) is commonly used for treating B-cell lymphoma that has returned or did not go away with other treatments. …